ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,732.46
-0.37%
Dow Jones
44,546.08
-0.37%
Gold vs US Dollar
2,882.735
0.00%
Brent Oil
74.39
0.00%
Bitcoin
96,897.09
-0.71%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Astria Therapeutics Inc (ATXS) Share Price

ATXS Astria Therapeutics Inc

7.06
0.04 (0.57%)
15 Feb 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Astria Therapeutics Inc NASDAQ:ATXS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.04 0.57 7.06 6.80 7.80 7.22 6.985 7.03 204,454 00:33:36   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -72.89M -1.2916 -6.61 396.17M
 Type  Size  Price  Time  Units 
 9 1 7.12 22:46:13 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ATXS News
14/02/202523:13EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14/02/202520:45EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
04/02/202521:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/02/202513:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference
03/02/202513:00BWAstria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session
23/01/202513:00BWAstria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
13/01/202513:09EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for ATXS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Astria Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads